Somatic mutations and altered regulation of EGFR pathway genes have been widely implicated in the development and prognosis of esophageal and gastric cancers [6], [7], [8], [9], [10], [11], [12], [13], [14], [15]. The gene discussed is EGFR; the disease is gastric cancer.